VAL-9
ESe019-A
General
Donor Information
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | |
Ethics
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
| Alternatives to consent are available? | Yes |
| Alternatives to consent | |
| Alternative consent approval number | |
| How may genetic information associated with the cell line be accessed? | |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
| Name of accrediting authority involved? | Ethics board of the Prince Felipe Research Centre |
| Approval number |
hESC Derivation
| Date of derivation | 2008-10-20 |
| Embryo stage | Morula |
| Supernumerary embryos from IVF treatment? |
Yes
|
| PGD Embryo? |
No |
| ZP removal technique | Chemical |
| Cell isolation | None |
| Cell seeding | Isolated ICM |
Culture Conditions
| Surface coating | Gelatin | ||||||
| Feeder cells |
Human Foreskin fibroblasts Cellfinder Ont Id: CELDA_000001419 |
||||||
| O2 Concentration | 21 % | ||||||
| CO2 Concentration | 5 % | ||||||
| Medium |
VitroHES
Supplements
|
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|
||||
| NANOG |
Yes |
|
|
|||
| POU5F1 (OCT-4) |
Yes |
|
|
|||
| SSEA-4 |
Yes |
|
||||
| TRA 1-60 |
Yes |
|
||||
| TRA 1-81 |
Yes |
|
||||
| DNMT3B |
Yes |
|
||||
| GDF3 |
Yes |
|
||||
| Amy |
No |
|
||||
| Cripto |
Yes |
|
||||
| GABRB3 |
Yes |
|
||||
| Nfh |
No |
|
||||
| Ren |
No |
|
||||
| Telomerase Activity |
Yes |
|
Differentiation Potency
Certificate of Analysis |
|
| Is there a certificate of analysis available? |
Yes
Passage:
|
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46XY
Passage number: 41
|
Other Genotyping (Cell Line) |
|
Login to share your feedback, experiences or results with the research community.